Schedule 13D ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Security class unavailable · CUSIP: 252828108

Event date: 2023-09-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,665,011
Percent of class
1.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-101247
Form type
SC 13D/A
Filer
Atlas Venture Fund X, L.P.
CIK
CIK 1628098
Filed
Sep 15, 2023
Reporting period
Sep 11, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub